Seattle Children's Hospital (dba Seattle Children's Research Institute)

Patent Applications and Registrations

Patent applications and USPTO patent grants for Seattle Children's Hospital (dba Seattle Children's Research Institute).The latest application filed is for "bispecific or-gate chimeric antigen receptor responsive to cd19 and cd20".

Company Profile

31.0.35

Seattle Children's Hospital (dba Seattle Children's Research Institute) - Seattle WA US
Seattle Children's Hospital dba Seattle Children's Research Institute - 818 Stewart Street, Suite 603 WA US
Seattle Children's Hospital DBA Seattle Children's Research Institute - Seatlle WA US
Seattle Children's Hospital DBA Seattle Children's Research Institute - Seattle WA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Microenvironment Sensors To Regulate Engineered Gene Expression App 20220125951A1 -	2022-04-28
Cell-free Biofragment Compositions And Related Systems, Devices, And Methods App 20220120745A1 -	2022-04-21
Chimeric Cytokine Receptors App 20220096549A1 -	2022-03-31
Bispecific Or-gate Chimeric Antigen Receptor Responsive To Cd19 And Cd20 App 20210145880 - CHEN; Yvonne Y. ; et al.	2021-05-20
Production Of Engineered T-cells By Sleeping Beauty Transposon Coupled With Methotrexate Selection App 20210139583 - Jensen; Michael C. ; et al.	2021-05-13
Bispecific Car T-cells For Solid Tumor Targeting App 20210085719 - Jensen; Michael C.	2021-03-25
Heritable Epigenetic Modifications As Markers Of Chemotherapy Exposure App 20210071253 - Skinner; Michael K. ; et al.	2021-03-11
Expression Of Foxp3 In Edited Cd34+ Cells App 20210054376 - Rawlings; David J. ; et al.	2021-02-25
Method And Compositions For Cellular Immunotherapy App 20210052649 - Jensen; Michael C. ; et al.	2021-02-25
Closed-system Manufacturing Process For Car-t Cells App 20210040448 - Jensen; Michael C. ; et al.	2021-02-11
Cell Atlas Of Healthy And Diseased Tissues App 20210024997 - Shalek; Alexander K. ; et al.	2021-01-28
Il-13 Receptor Alpha 2 Targeted, Zetakine Directed T Cell Immunotherapy App 20210017246 - Tampella; Giacomo ; et al.	2021-01-21
Transgene Genetic Tags And Methods Of Use App 20210002364 - Jensen; Michael C. ; et al.	2021-01-07
Il-13 Receptor Alpha 2 (il13ra2) Chimeric Antigen Receptor For Tumor Specific T Cell Immunotherapy App 20210000875 - Tampella; Giacomo ; et al.	2021-01-07
Enhancing Endonuclease Based Gene Editing In Primary Cells App 20200377911 - Scharenberg; Andrew M. ; et al.	2020-12-03
Fluorescein-specific Cars Exhibiting Optimal T Cell Function Against Fl-ple Labelled Tumors App 20200354477 - Jensen; Michael C. ; et al.	2020-11-12
Therapeutic Genome Editing In Wiskott-aldrich Syndrome And X-linked Thrombocytopenia App 20200325494 - Rawlings; David J. ; et al.	2020-10-15
Optimized Lentiviral Vector For Xla Gene Therapy App 20200325458 - Rawlings; David J. ; et al.	2020-10-15
Chimeric Transcription Factor Variants With Augmented Sensitivity To Drug Ligand Induction Of Transgene Expression In Mammalian Cells App 20200181624A1 -	2020-06-11
Genetic Engineering Of Macrophages For Immunotherapy App 20200155597A1 -	2020-05-21
Methods Of Exogenous Drug Activation Of Chemical-induced Signaling Complexes Expressed In Engineered Cells In Vitro And In Vivo App 20200123224A1 -	2020-04-23
Generating Mammalian T Cell Activation Inducible Synthetic Promoters (syn+pro) To Improve T Cell Therapy App 20200095573A1 -	2020-03-26
Phospholipid Ether (ple) Car T Cell Tumor Targeting (ctct) Agents App 20200087399A1 -	2020-03-19
Method And Compositions For Cellular Immunotherapy App 20200078405A1 -	2020-03-12
Methods Of Use For Car T Cells App 20190255109A1 -	2019-08-22
Drug Regulated Transgene Expression App 20190248891A1 -	2019-08-15
Method For Treating Autoimmune Disease Using Cd4 T-cells With Engineered Stabilization Of Expression Of Endogenous Foxp3 Gene App 20190247443A1 -	2019-08-15
Methods Of Use For Car T Cells App 20190224237A1 -	2019-07-25
Early Intervention Methods To Prevent Or Ameliorate Toxicity App 20190112379A1 -	2019-04-18
Tumor-specific Ifna Secretion By Car T-cells To Reprogram The Solid Tumor Microenvironment App 20190016776A1 -	2019-01-17
Method And Compositions For Cellular Immunotherapy App 20180009891 - Jensen; Michael C.	2018-01-11
BISPECIFIC OR-GATE CHIMERIC ANTIGEN RECEPTOR RESPONSIVE TO CD19 and CD20 App 20170368098 - CHEN; Yvonne Y. ; et al.	2017-12-28
Transgene Genetic Tags And Methods Of Use App 20170267742 - Jensen; Michael C. ; et al.	2017-09-21
Heritable Epigenetic Modifications As Markers Of Chemotherapy Exposure App 20170253927 - Skinner; Michael K. ; et al.	2017-09-07
Cysteamine In The Treatment Of Fibrotic Disease App 20170165207 - Eddy; Allison A. ; et al.	2017-06-15
Drug Regulated Transgene Expression App 20170152297 - Jensen; Michael C.	2017-06-01
Coupling Endonucleases With End-processing Enzymes Drives High Efficiency Gene Disruption App 20170152504 - Scharenberg; Andrew M. ; et al.	2017-06-01
Coupling Endonucleases With End-processing Enzymes Drives High Efficiency Gene Disruption App 20170152503 - Scharenberg; Andrew M. ; et al.	2017-06-01
Coupling Endonucleases With End-processing Enzymes Drives High Efficiency Gene Disruption App 20170152502 - Scharenberg; Andrew M. ; et al.	2017-06-01
Genetic Engineering Of Macrophages For Immunotherapy App 20170087185 - Crane; Courtney ; et al.	2017-03-30
Ccr5 Disruption Of Cells Expressing Anti-hiv Chimeric Antigen Receptor (car) Derived From Broadly Neutralizing Antibodies App 20170044240 - WAGNER; Thor ; et al.	2017-02-16
Inhibition Of Lactate Dehydrogenase 5 (ldh-5) Binding, Incorporation, Internalization And/or Endocytosis To Immune Cells App 20170029531 - Crane; Courtney	2017-02-02
Defined Composition Gene Modified T-cell Products App 20170015746 - Jensen; Michael C.	2017-01-19
Enhancing Endonuclease Based Gene Editing In Primary Cells App 20160333377 - Scharenberg; Andrew ; et al.	2016-11-17
Coupling Endonucleases With End-processing Enzymes Drives High Efficiency Gene Disruption App 20160312210 - Scharenberg; Andrew M. ; et al.	2016-10-27
Method And Compositions For Cellular Immunotherapy App 20150306141 - Jensen; Michael C. ; et al.	2015-10-29
Bispecific Chimeric Antigen Receptors And Therapeutic Uses Thereof App 20150038684 - Jensen; Michael	2015-02-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.